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ABSTRACT We have inactivated, by gene targeting, the
endogenous (2-microglobulin gene in a mouse embryonic stem
cell line. A cloned fragment of the fi2-microglobulin gene with
the coding sequence disrupted by the insertion of the neomycin-
resistance gene was used to transfect the embryonic stem cells.
G418-resistant colonies were selected and then screened using
the polymerase chain reaction to identify those in which the
incoming DNA had integrated into the embryonic stem cell
genome by homologous recombination. Of a total of 234
G418-resistant colonies screened, 2 correctly targeted colonies
were identified. Chimeric mice carrying the inactivated P2-
microglobulin gene have been obtained from both of these
targeted embryonic cell lines. Breeding of offspring from such
animals will allow investigation of the effects of homozygous
loss of (P2-microglobulin.
P32-Microglobulin (/32m) is a 99-amino acid polypeptide nec-
essary for the assembly and expression at the cell surface of
the many varieties of histocompatibility class I proteins,
including the highly polymorphic H2-K and H2-L/D pro-
teins. These proteins form complexes with viral, tumor, and
normal self antigens and display them to potentially respon-
sive cells (1, 2). Although the role of this presentation for
inducing and suppressing immune responses has been well
documented, its importance to the integrity of the complete
organism is not well understood. In addition, the complex
patterns of expression of various members of the class I
family have led to suggestions that they serve as differenti-
ation antigens critical for normal development, particularly
but perhaps not solely of cells in the immune system. f32m is
also required for expression of the products of the Qa/Tla
genes at the cell surface. These genes have a high level of
sequence homology with the classical class I antigens, but
they differ from them in not being polymorphic. It has not
been possible to assign a function to any of the Qa/Tla
antigens.
Low levels of H2-K and H2-D/L expression are first
detected during the midsomite stage ofembryogenesis (day 9)
when embryos have developed beyond primordial organo-
genesis and blood circulation has commenced. The level of
transcription of these genes remains low until day 13 of
gestation (3). Although class I antigens continue to be de-
tectable on virtually all somatic cells, the level of their
expression can vary 100-fold. A dramatic variation in expres-
sion occurs during maturation ofT cells, suggesting that class
I antigens play a role in this process. Although the classical
class I antigens do not seem to be expressed until the
midsomite stage of embryogenesis, /2m has been detected in
two- to eight-cell embryos (4). This ,32m may be associated
with the products of the Qa/TI region, since the Qa-2 antigen
has been detected in the two-cell to blastocyst stage of mouse
embryos (5).
The ability to create specific genetic mutations in embry-
onic stem cells (ES cells) (6) using homologous recombina-
tion (7, 8) and to transfer these mutations to the germ line (9,
10) provides an approach to many developmental questions.
As a first step toward better understanding the function of
P2m-associated antigens during development, we have dis-
rupted the ,2m gene in a mouse ES cell line using homologous
recombination. Two independent targeted ES cell lines con-
taining the disrupted f32m gene were identified using the
polymerase chain reaction (PCR) to screen for homologous
recombination events (11, 12). Chimeric mice have been
produced with both of these lines.
MATERIALS AND METHODS
Construction of the Targeting Plasmid. Plasmid pKCP2B
contains the entire ,32m gene within an 8.4-kilobase-pair (kbp)
Xho I fragment (13, 14). The 5' Xho I-BamHI fragment of this
gene was subcloned into pUC19. Two Kpn I restriction
enzyme sites, one in the 5' flankingDNA and the other within
the first intron, were removed by digestion with Kpn I
followed by treatment with T4 polymerase and religation. A
unique Cla I site was created in exon 2 by partial digestion
with EcoRI followed by treatment with the Klenow fragment
of DNA polymerase I and ligation with Cla I linkers. The
1150-bpXho I-BamHI fragment ofthe plasmid pMClNeo (8),
containing a neomycin-resistance gene driven by the Herpes
simplex virus thymidine kinase gene (HSV-tk) promoter and
a polyoma enhancer, was inserted into this Cla I site by using
linkers. Two plasmids, C65.2.3 and C65.5.9, were obtained
that differed in the transcriptional orientation of the inserted
fragment with respect to that of the P2m gene. The 5' Xho I
-Kpn I fragment of each of these was cloned into pUC19 to
obtain the targeting vectors used in our experiments. In
plasmid C84.4B the 5' to 3' orientation of the neomycin and
g32m promoters is identical (see Fig. 1). The opposite config-
uration occurs in plasmid C84.2D.
Culturing, Electroporation, and Selection of ES Cells. The
ES cell line E14TG2a (15) was cultured on mitomycin-treated
primary embryonic fibroblast-feeder layers essentially as
described (16). The embryonic fibroblasts were prepared
from embryos from C57BL/6 females that had mated 14-17
days earlier with a male homozygous for a neomycin-
resistance transgene (17); these cells are capable ofgrowth in
medium containing G418. Electroporation conditions were
similar to those that have been described (18). ES cells were
trypsinized, resuspended in culture medium at 4 x 107 cells
per ml, and electroporated in the presence of the targeting
DNA at 12 nM in the first experiment and 5 nM DNA in the
second. A voltage of 300 V with a capacitance of 150-250 ,uF
was found optimal with an electroporation cell of 5 mm length
Abbreviations: 932m, ,82-microglobulin; ES cell, embryonic stem cell;
PCR, polymerase chain reaction.
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and 100 mm2 cross-section (18). Approximately 5 x 106
electroporated cells were plated onto mitomycin-treated fi-
broblasts in 100-mm dishes containing Dulbecco's modified
Eagle's medium (DMEM) supplemented with 15% (vol/vol)
fetal bovine serum and 0.1 mM 2-mercaptoethanol. The
medium was replaced 24 hr after electroporation with me-
dium containing G418 (200 Ag/ml).
Analysis of G418-Resistant ES Cell Colonies. ES colonies
visible 10-14 days after electroporation were picked with
drawn-out capillary pipettes for analysis using the PCR. Half
of each picked colony was saved in 24-well plates already
seeded with mitomycin-treated feeder cells. The other
halves, combined in pools of three or four colonies, were
transferred to Eppendorf tubes containing -0.5 ml ofisotonic
phosphate-buffered saline (PBS) and analyzed for homolo-
gous recombination by PCR. Conditions for PCR reactions
were essentially as described (11). The ES cells were pel-
leted, resuspended in 5 A.l of PBS, and lysed by the addition
of 55 tkl of H20 to each tube. DNases were inactivated by
heating each tube at 950C for 10 min. After treatment with
proteinase K at 550C for 30 min, 30 ul of each lysate was
transferred to a tube containing 20 1.l of a reaction mixture
including PCR buffer, each primer at 1.5 ,ug, 3 units of
Thermus aquaticus polymerase, 10o (vol/vol) dimethyl sulf-
oxide, and 0.2 mM dATP, 0.2 mM dCTP, 0.2 mM dGTP, and
0.2 mM dTTP. PCR was carried out for 55 cycles using a
thermocycler modeled after one described (8), with a 65-sec
melt incubation at 92°C and a 10-min annealing and extension
incubation at 65°C. The two priming oligonucleotides, TG-
GCGGACCGCTATCCCCCAGGAC and GATGCTGAT-
CACATGTCTCG, correspond, respectively, to sequences
located 650 bases to the 3' side of the start codon of the
neomycin gene and sequences located in exon 3 of the 832m
gene. The reaction mixture (20 ,l) was electrophoresed on
agarose gels and transferred to nylon membranes (Zeta Bind).
Filters were probed with a 32P-labeled 450-bp EcoRI-Kpn I
fragment of the 182m gene indicated in Fig. 1 (see below).
Preparation and Restriction Enzyme Analysis of Genomic
DNA. Genomic DNA was prepared from ES cells, whole
new-born mice, and mouse tails by conventional methods.
DNA was digested with restriction enzymes as directed by
the manufacturers, and fragments were separated on 0.7%
agarose gels. DNA was transferred to nylon membranes and
probed with the 32P-labeled fragment described above.
Embryo Manipulation and Blastocyst Injection. Mice were
purchased from either The Jackson Laboratory or Charles
River Breeding Laboratories. C57BL/6 blastocysts were
obtained from 3- to 4-week-old superovulated females. Uteri
were flushed with M2 medium (19) 3.5 days after ovulation.
Blastocysts were collected, washed several times in fresh M2
medium, and placed in a 100-,lI droplet of M2 under paraffin
oil. ES cells were trypsinized, washed once with fresh
DMEM, and diluted to -2 x 106cells per ml. Cells (5 ,ul) were
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added to the droplet containing the blastocysts. Between 10
and 15 ES cells were injected into the blastocoel of each
blastocyst. After injection, six to nine blastocysts were
returned to each uterine horn of pseudopregnant females
mated 2.5 days previously with vasectomized males. Both
C57BL/6 x DBA F1 and C57BL/6 x CBA F1 mice proved
to be excellent foster mothers that had a pregnancy rate close
to 100% and could raise small litters.
RESULTS
Strategy. The strategy used to inactivate the f2m gene by
homologous recombination with exogenous DNA is illus-
trated in Fig. 1. The incoming DNA had -5 kbp of sequence
in common with the native gene, and it was this common
sequence, extending from the 5' flanking region to the second
intron, that mediated the homologous recombination leading
to the modification of the target gene. After the recombina-
tion had occurred, the reading frame ofthe modified f32m gene
was disrupted by the neomycin-resistance gene inserted into
the second exon. Two Kpn I sites, one in the 5' flanking DNA
and one in the first intron, were removed in constructing the
targeting plasmid. A third site remained in the second intron;
it allowed the targeting plasmid DNA to be cut to provide
recombinogenic ends in the incomingDNA and facilitated the
use of Southern blot analysis to locate the 5' crossover site
in the homologous recombinants.
A mutant polyoma enhancer and a thymidine kinase pro-
moter were used to drive the neomycin gene in our construct.
They have been shown to be active in both EC and ES cells
(8, 20, 21), and we therefore expected that G418 could be used
to provide an efficient selection for cells that stably integrated
the targeting DNA into their genomes after electroporation.
Some initial experiments were carried out with DNA pre-
pared from the plasmid C84.2D in which the promoters of the
neomycin gene and the ,32m gene were oriented in opposite
directions. Surprisingly, electroporation of ES cells in the
presence of this DNA failed to yield any G418-resistant
colonies. Resistant colonies were nevertheless obtained
when the neomycin gene was released from the ,82m DNA by
digestion with the Cla I prior to electroporation. This shows
that the neomycin sequences in the plasmid were functional
and suggests that the 832m sequences inhibited transcription
initiating from the oppositely oriented neomycin promoter.
This effect was not seen with the plasmid C84.4B, in which
the neomycin gene and the f32m promoter were in the same
orientation. C84.4B was therefore used in all the experiments
described here.
Homologous integrants were distinguished from random
integrants by a PCR assay (11). This assay exploits the fact
that homologous recombination joins the incoming DNA to
chromosomal DNA in a predictable way. Two primers were
chosen so that their binding sites would be juxtaposed only
E K B
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FIG. 1. Planned disruption of the 02m gene. (a) Native j32m locus of mouse. (b) Targeting DNA isolated from plasmid C84.4B. (c) Expected
structure of the locus after gene targeting by homologous recombination. Thin line, introns and flanking DNA; solid boxes, exons; open box,
neomycin-resistance (neo) gene. Restriction sites present in the native locus but removed from the targeting DNA are marked by an asterisk.
B, BamHI; E, EcoRI; K, Kpn I; X, Xba I; Xh, Xho I. The primers used for PCR are shown as arrows, and the 910-bp fragment that will be
amplified in the recombinants is indicated by a wavy line. The DNA fragment used as a probe in the analysis of Southern blots generated during
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after homologous integration of the incoming plasmid into the
182m gene. The inserted neomycin gene provided one primer
binding site. The second primer bound to a region of the f32m
gene that was not included in the incoming DNA but would
be located downstream of the neomycin gene after the
homologous recombination event. Amplification of cellular
DNA by PCR with these two primers was expected to yield
a fragment of 910 bp only when DNA from a successfully
targeted cell was present.
Isolation and Characterization of Targeted ES Cells. Two
independent targeting experiments were carried out. In each,
the ES cells were electroporated in the presence of the
incoming DNA and were then cultured in medium containing
G418. After about 2 weeks, several hundred G418-resistant
colonies were apparent. A portion of each of about 100
colonies was then transferred to an individual well of a
24-well plate, while the remaining portion was pooled with
portions from two to four other colonies for PCR analysis. In
the first experiment (Table 1), one pool gave a positive PCR
signal out of 32 pools analyzed that included a total of 100
G418-resistant colonies. The three individual colonies that
had contributed to this positive pool were analyzed individ-
ually by PCR, and a positive clone, ES39B, was identified.
Similar analysis of 134 G418-resistant colonies sampled in the
second experiment also yielded a clone, ES22A, which
generated the 910-bp DNA fragment, indicating successful
targeting when subjected to PCR.
To verify the targeted disruption of one copy of the /32m
gene, (the gene is autosomal and present in two copies), the
two PCR-positive clones, ES39B and ES22A, were ex-
panded, and their DNA was isolated and then analyzed by
Southern blotting using a probe that detects sequences from
the second exon and part of the first intron of the f32m gene
(Fig. 2). Patterns obtained with Xba I, BamHI, and Kpn I
matched those expected if one of the two copies of the /32m
gene had been disrupted in the planned manner (see Fig. 1)
in the PCR-positive clones. That is, one DNA fragment
identical in size to that present in untreated cells, but of
decreased intensity in the PCR-positive clones, was present
with all three enzymes. An additional fragment of the size
predicted for a homologous recombination event was present
only in the PCR-positive clones. The insertion of the neo-
mycin gene in the second exon by the recombination resulted
in an Xba I fragment detectable with the 832m-specific probe
that is -1 kilobase (kb) longer than the equivalent fragment
in the native locus. A new BamHI site was introduced into the
locus by the targeting DNA, reducing the size of the BamHI
fragment detected by the /32m probe from 10.6 kbp to 900 bp.
A new fragment was also seen after Kpn I digestion. In
ES39B, the Kpn I fragment was 7 kb long, as predicted by a
crossover between the 5' end of the targeting plasmid and the
native locus. In ES22A this new Kpn I fragment was 4.0 kb
long, which shows that the deleted Kpn I sites were not
incorporated into the locus. This observation indicates that
one of the crossovers in cell line ES22A resolved between the
third Kpn I site of the native locus and the inserted neomycin
gene of the incoming DNA, presumably after branch migra-
tion of a crossover intermediate. Although the 5' crossover
sites differ, both modified cell lines now contain a P32m gene
disrupted in the planned way by insertion of a neomycin gene
Table 1. Homologous recombination into the mouse /32m locus
G418r
E14 G418 colonies ES cells
cells treated, colonies analyzed by correctly
Exp. no. x 10-7 obtained, no. PCR, no. targeted, no.
1 12 602 100 1
2 3.5 244 134 1
G418r, G418 resistant.
BamHI KpnI XbaI
I Ir 11 ---- I
o
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W Cl WSM- C LU N cOZ
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FIG. 2. Southern blot analysis ofthe ,2m locus. DNA samples are
from the parental cell line E14 (E14TG2a), two targeted cell lines
[ES22A (22a) and ES39B (39)], and from a newborn pup of a mouse
who had received blastocysts injected with ES22A cells. Genomic
DNA (10 jg) was digested with the restriction endonuclease indi-
cated and probed with the fragment shown in Fig. 1. Arrows indicate
bands that hybridized when the filter was reprobed with a probe
specific for the neomycin gene.
in exon 2. Rehybridization of the filter used for the autora-
diograph illustrated in Fig. 2 with a probe for the neomycin
gene showed that the only bands that hybridized were those
predicted by the structure shown in Fig. 1. They are marked
by small arrows in Fig. 2.
Chimeric Offspring of Targeted ES Cells. ES cell lines
carrying inactivated f32m genes should allow the introduction
of this mutation into the mouse germ line. Toward this end,
we injected 10-15 cells from each of the targeted ES cell lines
into C57BL/6 blastocysts. Embryos were reimplanted into
pseudopregnant females. Because the initial ES cell line
E14TG2a was isolated from strain 129/Ola embryos, it and all
cell lines derived from it carry the coat color markers
characteristic of this mouse strain. These include the domi-
nant A" allele at the agouti locus, the recessive chinchilla
allele at the c locus, and the recessive p allele (pink-eyed
dilution) at the p locus (9). Contribution of ES cells to the
mesoderm-derived portions of hair follicles results in an
agouti coat. Hair follicles to which melanocytes of ES cell
origin (and therefore carrying the p and c'h mutations) have
migrated produce cream colored hairs. Both of these coat
colors are easily distinguished from the solid black coat seen
in pups derived from nonagouti C57BL/6 host blastocysts.
The efficiency with which blastocysts injected with the two
targeted cell lines produced coat color chimeras is shown in
Table 2. More than 70% of surviving pups were chimeras.
DNA isolated from a newborn pup of a female implanted with
blastocysts injected with ES22A is shown in the farthest lane
Table 2. Chimera production from p2m-targeted ES cell lines
Cell Progeny, Chimeras, Male/female
line no. no. % chimeras ratio
E1439B 23 17 74 10/7
E1422A 26 21 81 6/15
__4 w
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to the right in Fig. 2. The intensity of the 6.1-kb Xba I band
diagnostic of the targeted f32m locus shows that the modified
ES cells contributed extensively to the tissue of this animal.
DISCUSSION
In a total of 234 G418-resistant colonies screened for homol-
ogous recombination, two targeting events at the f32m locus
have been identified. Comparisons of this frequency to those
obtained for other loci are complicated by a number of
factors. If a comparison is made on the basis of cells
electroporated, it is necessary to take into account variables
such as cell death during electroporation and the plating
efficiency of the ES cells. When comparison is made on the
basis of the number of cells transformed by the incoming
DNA, the ratio of targeted to G418-resistant colonies in
experiments carried out by various investigators is affected
by the strength of the specific promoter and enhancer used to
drive the neomycin gene, for this affects its ability to function
in sites of random versus targeted integration. Although
strong promoters may be desirable to assure expression of
the neomycin gene when it is inserted into a target locus that
is unexpressed or poorly expressed, they increase substan-
tially the number of sites at which random integration will
confer G418 resistance on the resulting cells (8). This in turn
will increase the number of colonies that must be screened to
identify a targeted cell. Comparisons of frequencies are
further complicated by the fact that promoterless neomycin
genes lacking poly(A) sites are often used to enrich for
targeting. We have also found that the strength of a promoter
can vary in constructs, depending on the DNA in which it is
embedded and even on its orientation. For example, no
G418-resistant colonies were obtained with our present con-
struction when the neomycin gene was in the reverse orien-
tation relative to the f32m gene. With these difficulties in
mind, the following comparisons are presented of targeting
events/G418-resistant colonies: 1/117 for the f32m gene (this
work), 1/300 for en-2 (12), 1/950 for hprt (8), and 1/400,000
for int-2 (22).
The high frequency with which the P2m locus was targeted
is somewhat surprising, for it has been suggested that the
level ofexpression ofa gene may be one factor influencing the
frequency of targeting (22). For example, the low frequency
with which int-2 was targeted was suggested to be a reflection
of an expression level of only 0.5 copy per cell. No P2m
protein can be seen by fluorescent antibody techniques in the
cell surface of ES cells (unpublished observations), and,
although no data are specifically available for ES cells, the
closely related EC cell lines do not show detectable f82m
mRNA (23). Thus our data suggest that gene targeting with
DNA containing the neomycin gene may be feasible for
nonexpressed genes. Certainly the frequency of targeting is
not easily correlated with the level of expression of the gene
being targeted. This lack of correlation is supported by our
lack of success in targeting the 382m gene in mouse L cells
(unpublished data), which clearly express this gene. When
frequency comparisons are made on the basis of targeting
events per starting cell, the following frequencies per 107 cells
are obtained: for the 832m gene, 0.5; for en-2, 0.7; for hprt, 1.3;
and for int-2, 1.3. Thus all four loci are essentially the same
when compared in this way.
Both of the targeted cell lines that we have isolated in
which the 182m gene has been inactivated have been intro-
duced into blastocysts, and chimeric animals have been
obtained at high frequencies. Obtaining these chimeras es-
tablishes, not surprisingly, that cells heterozygous for an
inactive ,B2m gene- are viable in the whole animal. We can
therefore expect that animals fully heterozygous for that
genotype will survive. Such animals should be obtained when
the present crop of chimeras (or others comparable to them)
are old enough to transmit the inactivated 12m gene to their
progeny. The most dramatic and revealing observations on
the function of 82m and its associated proteins during devel-
opment are likely to come when these progeny are interbred
to obtain the inactivation in a homozygous form. An alter-
native approach to studying homozygosity is to make chi-
meras by injecting normal blastocysts with ES cells that have
both 82m genes inactivated. Accordingly we intend to inac-
tivate the second gene in our ES cells once they have been
proven germ-line competent. In this way the effects of
absence of f82m and P2m-dependent proteins in a fraction of
the cells of a developing chimeric embryo can be studied.
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